Young women diagnosed with breast cancer have a relatively low risk of isolated locoregional recurrence (LRR) after initial treatment, according to a large retrospective study. Among a cohort of 1,135 ...

For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a study published online July 23 in JAMA Surgery.

Locoregional recurrence in breast cancer denotes the reappearance of tumour within the ipsilateral breast, chest wall or regional lymphatic basins after initial curative-intent treatment. Management ...

A new study suggests that age is an independent risk factor for late distant recurrence among younger patients with ER-positive, ERBB2-negative breast cancer. In the analysis, patients aged 21-35 ...

Adjuvant radiation and endocrine therapy significantly reduce locoregional recurrence in early-stage breast cancer post-lumpectomy, especially in low-risk patients. Radiation therapy notably decreases ...

LAGUNA HILLS, Calif., March 12, 2026 /PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today the publication of results from ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...

The risk of isolated locoregional recurrence after initial treatment was 5.6% among young women diagnosed with breast cancer. This was lower than a previously reported 10-year rate of 8% among all ...